Results from the Survey of Antibiotic Resistance (SOAR) 2015-17 in the Middle East (Kuwait, Lebanon and Saudi Arabia): data based on CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints
Affiliations
Affiliations
- GlaxoSmithKline, 980 Great West Road, Brentford, Middlesex TW8 9GS, UK.
- Microbiology Department, Faculty of Medicine, Kuwait University, Jabrya, Kuwait.
- Department of Medical Microbiology and Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia and Clinical and Molecular Microbiology Laboratory, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
- Pathology and Clinical Laboratory Medicine Administration, King Fahad Medical City, Dhabab Street, PO Box 59046 Riyadh, Saudi Arabia.
- Faculty of Medicine and Medical Sciences, University of Balamand, Al Koura, Tripoli, Lebanon.
- IHMA Europe Sàrl, Route de l'Ile-au-Bois 1A, 1870 Monthey/VS, Switzerland.
Abstract
Objectives: To determine antibiotic susceptibility of Streptococcus pneumoniae and Haemophilus influenzae isolates from community-acquired respiratory tract infections (CA-RTIs) collected in 2015-17 from Kuwait, Lebanon and Saudi Arabia.
Methods: MICs were determined by CLSI broth microdilution and susceptibility was assessed using CLSI, EUCAST (dose-specific) and pharmacokinetic/pharmacodynamic (PK/PD) breakpoints.
Results: A total of 139 S. pneumoniae isolates were collected from four centres in Kuwait, Lebanon and Saudi Arabia in 2015-17 and 55 H. influenzae isolates were collected and analysed from Saudi Arabia over the same time period. Pneumococci from all three countries were commonly non-susceptible to penicillin based on CLSI oral or low-dose IV penicillin using EUCAST breakpoints (39% in Kuwait to 57.1% in Lebanon) but by CLSI IV and EUCAST high-dose breakpoints most isolates were susceptible (∼90% in Kuwait and Saudi Arabia, and 100% in Lebanon). Isolates from Lebanon were highly susceptible to most other antibiotics (>90%) except cefaclor, oral cefuroxime and cefpodoxime (EUCAST breakpoints only). Overall, susceptibility was significantly lower in Kuwait and Saudi Arabia than Lebanon. Although all H. influenzae isolates (Saudi Arabia only) were β-lactamase negative, 3.6% and 12.7% were ampicillin resistant by CLSI and EUCAST breakpoints, respectively. Otherwise susceptibility was high in H. influenzae. The application of different EUCAST breakpoints for low and higher doses for some of the antibiotics (amoxicillin, amoxicillin/clavulanic acid, ampicillin, penicillin, ceftriaxone, clarithromycin, erythromycin, levofloxacin and trimethoprim/sulfamethoxazole) allowed, for the first time in a SOAR study, the effect of raising the dosage on susceptibility to be quantified.
Conclusions: Relatively low antibiotic susceptibility was observed in S. pneumoniae from Kuwait and Saudi Arabia in contrast to Lebanon, where rates of susceptibility were generally higher. Isolates of H. influenzae from Saudi Arabia were susceptible to most antibiotics. These factors are important in decision making for empirical therapy of CA-RTIs.
Similar articles
Torumkuney D, Bratus E, Yuvko O, Pertseva T, Morrissey I.J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i100-i111. doi: 10.1093/jac/dkaa087.PMID: 32337596
Torumkuney D, Tunger A, Sancak B, Bıçakçıgil A, Altun B, Aktas Z, Kayacan C, Morrissey I.J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i88-i99. doi: 10.1093/jac/dkaa086.PMID: 32337598
Torumkuney D, Anwar S, Nizamuddin S, Malik N, Morrissey I.J Antimicrob Chemother. 2020 Apr 1;75(Suppl 1):i76-i87. doi: 10.1093/jac/dkaa085.PMID: 32337594
Memish ZA, Osoba AO, Shibl AM, Mokaddas E, Venkatesh S, Rotimi VO.J Chemother. 2007 Oct;19(5):471-81. doi: 10.1179/joc.2007.19.5.471.PMID: 18073145 Review.
How can we predict bacterial eradication?
Jacobs MR.Int J Infect Dis. 2003 Mar;7 Suppl 1:S13-20. doi: 10.1016/s1201-9712(03)90066-x.PMID: 12839703 Review.
Cited by
Torumkuney D, Dolgum S, van Hasselt J, Abdullah W, Keles N.J Antimicrob Chemother. 2022 Sep 6;77(Suppl_1):i70-i76. doi: 10.1093/jac/dkac219.PMID: 36065727 Free PMC article.
Torumkuney D, Behbehani N, van Hasselt J, Hamouda M, Keles N.J Antimicrob Chemother. 2022 Sep 6;77(Suppl_1):i77-i83. doi: 10.1093/jac/dkac220.PMID: 36065725 Free PMC article.
The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials.
Rodríguez-Gascón A, Solinís MÁ, Isla A.Pharmaceutics. 2021 Jun 3;13(6):833. doi: 10.3390/pharmaceutics13060833.PMID: 34205113 Free PMC article. Review.
Genomic Assays in Node Positive Breast Cancer Patients: A Review.
Bou Zerdan M, Ibrahim M, Nakib CE, Hajjar R, Assi HI.Front Oncol. 2021 Feb 16;10:609100. doi: 10.3389/fonc.2020.609100. eCollection 2020.PMID: 33665165 Free PMC article. Review.